Loss of the ex vivo but not the reinducible CD8+ T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia/lymphoma.
about
HTLV-1 tax specific CD8+ T cells express low levels of Tim-3 in HTLV-1 infection: implications for progression to neurological complicationsHTLV-1 specific CD8+ T cell function augmented by blockade of 2B4/CD48 interaction in HTLV-1 infectionIn vivo immunogenicity of Tax(11-19) epitope in HLA-A2/DTR transgenic mice: implication for dendritic cell-based anti-HTLV-1 vaccineReduction of human T-cell leukemia virus type 1 (HTLV-1) proviral loads in rats orally infected with HTLV-1 by reimmunization with HTLV-1-infected cells.Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+ T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriersAdult T-cell leukemia: future prophylaxis and immunotherapy.Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from JamaicaIn vivo and in vitro treatment of HTLV-1 and HTLV-2 infected cells with arsenic trioxide and interferon-alpha.Tumor immunity against adult T-cell leukemia.T Cell Receptor Vβ Staining Identifies the Malignant Clone in Adult T cell Leukemia and Reveals Killing of Leukemia Cells by Autologous CD8+ T cells.Animals Models of Human T Cell Leukemia Virus Type I Leukemogenesis.Activation and detection of HTLV-I Tax-specific CTLs by epitope expressing single-chain trimers of MHC class I in a rat modelLack of recall response to Tax in ATL and HAM/TSP patients but not in asymptomatic carriers of human T-cell leukemia virus type 1.Double control systems for human T-cell leukemia virus type 1 by innate and acquired immunity.HTLV-1 Tax-Specific CTL Epitope-Pulsed Dendritic Cell Therapy Reduces Proviral Load in Infected Rats with Immune Tolerance against Tax.Clinical significance of CD70 expression on T cells in human T-lymphotropic virus type-1 carriers and adult T cell leukemia/ lymphoma patients.The roles of acquired and innate immunity in human T-cell leukemia virus type 1-mediated diseases.The combination of IκB kinase β inhibitor and everolimus modulates expression of interleukin-10 in human T-cell lymphotropic virus type-1-infected T cells.Long-term persistence of limited HTLV-I Tax-specific cytotoxic T cell clones in a patient with adult T cell leukemia/lymphoma after allogeneic stem cell transplantation.Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells.IL-10-mediated signals act as a switch for lymphoproliferation in Human T-cell leukemia virus type-1 infection by activating the STAT3 and IRF4 pathways.In vitro peptide immunization of target tax protein human T-cell leukemia virus type 1-specific CD4+ helper T lymphocytes.Is There a Role for HTLV-1-Specific CTL in Adult T-Cell Leukemia/Lymphoma?Pediatric T- and NK-cell lymphomas: new biologic insights and treatment strategies.Depletion and impaired interferon-alpha-producing capacity of blood plasmacytoid dendritic cells in human T-cell leukaemia virus type I-infected individuals.Aspects moléculaires des lymphomes T périphériques (2)
P2860
Q24607794-85227E6F-0340-430D-868A-318A18E8AA55Q31151159-13F2404A-D300-4A6C-82F5-722D68013834Q33709237-37866967-546E-4A97-8A6F-DA1B15A5C481Q35023802-A979933E-D7BC-44B7-A205-9A2C27512EB0Q35682461-9899DF61-9997-40ED-BBBF-6A3671A7441DQ35782912-D99EEED5-07B1-4FD8-A0B1-C552A545D9B2Q35891629-CFDA31B3-8642-4BAB-A8FC-0846FB483751Q35994968-5848CE8A-8087-4089-9EB2-F62CB48F167EQ36132707-457F3886-DEE9-474B-8BBB-802C968C9C5BQ36205736-241DF93A-58DD-4576-BE79-7B8F5A71E543Q36751592-82B33D64-A84D-4FF2-95DC-DD5D049A2C21Q36964053-8DA84E71-2D26-4E5C-A596-A5B29038FA3BQ37200968-33932E5A-AAA1-4E8E-B9C2-2FAA2051B8A7Q37827194-1C96E88F-3C69-4B66-B2D6-9C526977BC48Q38724542-8E49DA90-3D33-4402-B6CB-5AC127286FAFQ38863823-DA1D4FAB-44FC-427A-B505-078E965B9913Q39119670-B26670F4-3847-48F9-AEDD-C0056A61639FQ39218366-1F8377F5-1C3A-4841-85D5-537849587EA8Q39591412-F5120726-5DFA-4E2A-AC06-04901007BEE1Q39996982-2BA36B35-9D54-40AD-890E-2332968A7A38Q40041190-22912A3A-90B1-418F-B087-AFBB60FC1341Q40267146-182725AC-FC8A-4FF2-949B-B921B8EA84DDQ41723007-581D241B-A5CC-488E-A597-87AAC7789A78Q41942675-974B274F-B728-4265-B7E7-4FDA32F88BD3Q45639637-A5D24570-27F2-4A87-8A6D-8BAFD54DDE3AQ57216715-261592B3-542E-4940-BF01-0F12210C65D9
P2860
Loss of the ex vivo but not the reinducible CD8+ T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia/lymphoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Loss of the ex vivo but not th ...... dult T-cell leukemia/lymphoma.
@en
Loss of the ex vivo but not th ...... dult T-cell leukemia/lymphoma.
@nl
type
label
Loss of the ex vivo but not th ...... dult T-cell leukemia/lymphoma.
@en
Loss of the ex vivo but not th ...... dult T-cell leukemia/lymphoma.
@nl
prefLabel
Loss of the ex vivo but not th ...... dult T-cell leukemia/lymphoma.
@en
Loss of the ex vivo but not th ...... dult T-cell leukemia/lymphoma.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Loss of the ex vivo but not th ...... dult T-cell leukemia/lymphoma.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.LEU.2403176
P577
2004-01-01T00:00:00Z
P5875
P6179
1009385998